Docoh
Loading...

ALC Alcon Inc. - Registered Shares

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

ALC stock data

(
)

Calendar

23 Feb 21
25 Jan 22
31 Dec 22
Quarter (USD)
Dec 20 Dec 19 Mar 11 Mar 10
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Mar 11 Mar 10
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

44.5% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 548 540 +1.5%
Opened positions 60 62 -3.2%
Closed positions 52 58 -10.3%
Increased positions 187 177 +5.6%
Reduced positions 163 172 -5.2%
13F shares
Current Prev Q Change
Total value 17.63B 15.37B +14.6%
Total shares 218.85M 219.88M -0.5%
Total puts 749.01K 553.52K +35.3%
Total calls 4.43M 3.89M +13.9%
Total put/call ratio 0.2 0.1 +18.8%
Largest owners
Shares Value Change
Vanguard 14.98M $1.21B +2.6%
Aristotle Capital Management 14.37M $1.16B -0.8%
Clearbridge Advisors 12.33M $992.39M +0.1%
TROW T. Rowe Price 12.19M $987.23M +6.5%
CS Credit Suisse 12.17M $979.61M +0.8%
WCM Investment Management 6.5M $522.99M +2.7%
Schroder Investment Management 5.76M $437.89M -51.5%
Brown Brothers Harriman & Co 5.58M $449.31M -4.0%
Ako Capital 5.55M $448.92M -7.3%
WFC Wells Fargo & Co. 5.51M $443.5M -16.9%
Largest transactions
Shares Bought/sold Change
Schroder Investment Management 5.76M -6.1M -51.5%
GQG Partners 4.8M +4.8M NEW
Pictet Asset Management 0 -2.89M EXIT
Pictet Asset Management 2.64M +2.64M NEW
WFC Wells Fargo & Co. 5.51M -1.12M -16.9%
BLK Blackrock 3.54M -1.01M -22.2%
IVZ Invesco 466.45K -1M -68.2%
Acadian Asset Management 1.01M +974.13K +2449.7%
TROW T. Rowe Price 12.19M +745.51K +6.5%
Arrowstreet Capital, Limited Partnership 936.81K +706.5K +306.8%

Financial report summary

?
Competition
Oyster Point Pharma
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: AbbVie, absent, acquainted, ascertaining, Ave, backlog, bankruptcy, bedrock, Biogen, BlackRock, blink, Blueprint, bolstered, breakthrough, carryforward, CGU, character, chart, CNI, combat, compliant, conspired, contrary, Copr, Copre, coursework, crucial, discovered, donated, door, DPA, ecosystem, EDoF, emptive, escrow, EssilorLuxottica, experiential, explanatory, extrapolated, falsify, feel, foramortization, frontline, frozen, furlough, FY, grid, healthy, Helpline, holistic, Hypervit, iconic, inflow, JJSVI, KGaA, lifelong, lifted, Lonza, magnitude, Mannheim, MDPF, meal, mentoring, native, notwithstanding, OPEB, outpaced, outperformed, override, pandemic, Parliament, PG, pilot, piloted, PPE, QMS, rank, rebound, rebounding, reconsider, reintroduced, reopened, Root, rounding, sanitizer, slowdown, Southeast, splash, standstill, stem, Stryker, suggesting, survey, temperature, Throgmorton, tiny, transitory, tunable, unabsorbed, underwent, unlocking, valuable, Vietnam, vitally, Vivity, workplace, workstation, WTW
Removed: abandon, added, affirmed, Alternatively, attending, attracting, bad, cachet, CERTIFYING, CH, Circuit, Coast, complicated, consumable, disagreement, disposed, distant, easier, expiring, fashion, fastest, flagship, formulated, globe, hydrogel, infringe, initiative, leased, lubricant, matrix, meaningful, Modernization, nevanac, October, opposition, oral, outpatient, patented, phakic, PMA, priority, progressed, progression, promoted, reaching, relocate, restated, retrospective, silicone, soft, solution, stating, sterile, stricter, tangible, taxpayer, thereto, thirty, TIMETABLE, unfavorable, unresolved, Vigamox, West, wetting, Wirz

Proxies

No filings

Patents

GRANT
Utility
Foot controller with adjustable treadle
23 Feb 21
The disclosed embodiments of the present technology relate to a foot controller with an adjustable treadle assembly including an adjustable treadle surface member slidably coupled to a fixed treadle plate and a latch assembly to adjust the adjustable treadle surface member to fixed positions relative to the treadle plate.
GRANT
Utility
Lipid-based ophthalmic emulsion
23 Feb 21
The present invention is directed to a lipid-based ophthalmic emulsion.
APP
Utility
Eye Tracking Fixation Monitoring Systems and Methods
18 Feb 21
Systems and methods for tracking eye movement during a diagnostic procedure include a retina imaging system configured to capture a first plurality of images of an eye and detect a presence of a fovea, an eye tracker configured to capture a second plurality of images of the eye and track a position and orientation of the eye; and a control processor configured to synchronize the first and second plurality of images, determine a time at which the fovea is detected in the first plurality of images, and determine one or more images from the second plurality of images to be classified as representative of fixation.
APP
Utility
Eye Tracking Fixation Monitoring Systems and Methods
18 Feb 21
Systems and methods for tracking eye movement during a diagnostic procedure include an eye tracker capturing images of an eye, and a control processor configured to detect an eye position and orientation in each of the images, determine an eye fixation position and orientation relative to an optical axis of the eye tracker, estimate eye fixation parameters based at least in part on the determined eye fixation position and orientation, and track the eye position and orientation by analyzing the images to determine the eye position and orientation relative to the eye fixation parameters.
GRANT
Utility
Vitrectomy probe with integral valve
16 Feb 21
A vitrectomy apparatus for performing an ocular surgery may include a vitrectomy probe body graspable by a user and a cutter extending from the body and comprising an inner tube and an outer tube.